دورية أكاديمية
أعرض في EDS

Interventions for improving coverage of childhood immunisation in low- and middle-income countries.

التفاصيل البيبلوغرافية
العنوان: Interventions for improving coverage of childhood immunisation in low- and middle-income countries.
المؤلفون: Oyo-Ita A; Department of Community Health, University of Calabar Teaching Hospital, Calabar, Nigeria., Oduwole O; Department of Medical Laboratory Science, Achievers University, Owo, Nigeria., Arikpo D; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria., Effa EE; Internal Medicine, College of Medical Sciences, University of Calabar, Calabar, Nigeria., Esu EB; Department of Public Health, College of Medical Sciences, University of Calabar, Calabar, Nigeria., Balakrishna Y; Biostatistics Unit, South African Medical Research Council, Durban, South Africa., Chibuzor MT; Cochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria., Oringanje CM; GIDP Entomology and Insect Science, University of Tucson, Tucson, Arizona, USA., Nwachukwu CE; Excellence & Friends Management Consult (EFMC), Abuja, Nigeria., Wiysonge CS; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.; Vaccine-Preventable Diseases Programme, World Health Organization Regional Office for Africa, Cité du Djoué, Brazzaville, Congo., Meremikwu MM; Department of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria.
المصدر: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2023 Dec 06; Vol. 12. Cochrane AN: CD008145. Date of Electronic Publication: 2023 Dec 06.
نوع المنشور: Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE
أسماء مطبوعة: Publication: 2004- : Chichester, West Sussex, England : Wiley
Original Publication: Oxford, U.K. ; Vista, CA : Update Software,
مواضيع طبية MeSH: Developing Countries* , Vaccines*, Child ; Humans ; Infant ; Immunization ; Vaccination ; Health Education ; Randomized Controlled Trials as Topic
مستخلص: Background: Immunisation plays a major role in reducing childhood morbidity and mortality. Getting children immunised against potentially fatal and debilitating vaccine-preventable diseases remains a challenge despite the availability of efficacious vaccines, particularly in low- and middle-income countries. With the introduction of new vaccines, this becomes increasingly difficult. There is therefore a current need to synthesise the available evidence on the strategies used to bridge this gap. This is a second update of the Cochrane Review first published in 2011 and updated in 2016, and it focuses on interventions for improving childhood immunisation coverage in low- and middle-income countries.
Objectives: To evaluate the effectiveness of intervention strategies to boost demand and supply of childhood vaccines, and sustain high childhood immunisation coverage in low- and middle-income countries.
Search Methods: We searched CENTRAL, MEDLINE, CINAHL, and Global Index Medicus (11 July 2022). We searched Embase, LILACS, and Sociological Abstracts (2 September 2014). We searched WHO ICTRP and ClinicalTrials.gov (11 July 2022). In addition, we screened reference lists of relevant systematic reviews for potentially eligible studies, and carried out a citation search for 14 of the included studies (19 February 2020).
Selection Criteria: Eligible studies were randomised controlled trials (RCTs), non-randomised RCTs (nRCTs), controlled before-after studies, and interrupted time series conducted in low- and middle-income countries involving children that were under five years of age, caregivers, and healthcare providers.
Data Collection and Analysis: We independently screened the search output, reviewed full texts of potentially eligible articles, assessed the risk of bias, and extracted data in duplicate, resolving discrepancies by consensus. We conducted random-effects meta-analyses and used GRADE to assess the certainty of the evidence.
Main Results: Forty-one studies involving 100,747 participants are included in the review. Twenty studies were cluster-randomised and 15 studies were individually randomised controlled trials. Six studies were quasi-randomised. The studies were conducted in four upper-middle-income countries (China, Georgia, Mexico, Guatemala), 11 lower-middle-income countries (Côte d'Ivoire, Ghana, Honduras, India, Indonesia, Kenya, Nigeria, Nepal, Nicaragua, Pakistan, Zimbabwe), and three lower-income countries (Afghanistan, Mali, Rwanda). The interventions evaluated in the studies were health education (seven studies), patient reminders (13 studies), digital register (two studies), household incentives (three studies), regular immunisation outreach sessions (two studies), home visits (one study), supportive supervision (two studies), integration of immunisation services with intermittent preventive treatment of malaria (one study), payment for performance (two studies), engagement of community leaders (one study), training on interpersonal communication skills (one study), and logistic support to health facilities (one study). We judged nine of the included studies to have low risk of bias; the risk of bias in eight studies was unclear and 24 studies had high risk of bias. We found low-certainty evidence that health education (risk ratio (RR) 1.36, 95% confidence interval (CI) 1.15 to 1.62; 6 studies, 4375 participants) and home-based records (RR 1.36, 95% CI 1.06 to 1.75; 3 studies, 4019 participants) may improve coverage with DTP3/Penta 3 vaccine. Phone calls/short messages may have little or no effect on DTP3/Penta 3 vaccine uptake (RR 1.12, 95% CI 1.00 to 1.25; 6 studies, 3869 participants; low-certainty evidence); wearable reminders probably have little or no effect on DTP3/Penta 3 uptake (RR 1.02, 95% CI 0.97 to 1.07; 2 studies, 1567 participants; moderate-certainty evidence). Use of community leaders in combination with provider intervention probably increases the uptake of DTP3/Penta 3 vaccine (RR 1.37, 95% CI 1.11 to 1.69; 1 study, 2020 participants; moderate-certainty evidence). We are uncertain about the effect of immunisation outreach on DTP3/Penta 3 vaccine uptake in children under two years of age (RR 1.32, 95% CI 1.11 to 1.56; 1 study, 541 participants; very low-certainty evidence). We are also uncertain about the following interventions improving full vaccination of children under two years of age: training of health providers on interpersonal communication skills (RR 5.65, 95% CI 3.62 to 8.83; 1 study, 420 participants; very low-certainty evidence), and home visits (RR 1.29, 95% CI 1.15 to 1.45; 1 study, 419 participants; very low-certainty evidence). The same applies to the effect of training of health providers on interpersonal communication skills on the uptake of DTP3/Penta 3 by one year of age (very low-certainty evidence). The integration of immunisation with other services may, however, improve full vaccination (RR 1.29, 95% CI 1.16 to 1.44; 1 study, 1700 participants; low-certainty evidence).
Authors' Conclusions: Health education, home-based records, a combination of involvement of community leaders with health provider intervention, and integration of immunisation services may improve vaccine uptake. The certainty of the evidence for the included interventions ranged from moderate to very low. Low certainty of the evidence implies that the true effect of the interventions might be markedly different from the estimated effect. Further, more rigorous RCTs are, therefore, required to generate high-certainty evidence to inform policy and practice.
(Copyright © 2023 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.)
التعليقات: Update of: Cochrane Database Syst Rev. 2016 Jul 10;7:CD008145. doi: 10.1002/14651858.CD008145.pub3. (PMID: 27394698)
References: J Infect Dis. 2012 Mar;205 Suppl 1:S4-5. (PMID: 22315384)
Cochrane Database Syst Rev. 2020 Jul 14;8:CD013679. (PMID: 32813276)
Health Educ Res. 1998 Mar;13(1):87-108. (PMID: 10178339)
Lancet. 2012 Jun 9;379(9832):2151-61. (PMID: 22579125)
Immunity. 2017 Mar 21;46(3):350-363. (PMID: 28329702)
Trop Doct. 2001 Jan;31(1):21-4. (PMID: 11205594)
BMC Public Health. 2015 Jul 15;15:664. (PMID: 26173803)
S Afr Med J. 1990 Dec 15;78(12):729-33. (PMID: 2251630)
MMWR Morb Mortal Wkly Rep. 2006 May 12;55(18):511-5. (PMID: 16691182)
Vaccine. 2005 Feb 18;23(13):1624-35. (PMID: 15694515)
Health Promot Int. 2021 Aug 24;36(3):765-773. (PMID: 33057615)
Vaccine. 2020 Feb 24;38(9):2209-2215. (PMID: 31983583)
Int J Public Health. 2015 Nov;60(7):767-80. (PMID: 26298444)
Hum Resour Health. 2009 Nov 03;7:81. (PMID: 19887002)
Vaccine. 2000 Feb 18;18 Suppl 1:S44-5. (PMID: 10683545)
Pediatrics. 2018 Apr;141(4):. (PMID: 29540571)
BMC Public Health. 2006 May 17;6:132. (PMID: 16707013)
Vaccine. 2019 Sep 30;37(42):6192-6200. (PMID: 31492475)
Bull World Health Organ. 2004 Sep;82(9):689-96. (PMID: 15628207)
Matern Child Health J. 2019 Dec;23(12):1658-1669. (PMID: 31584144)
J Public Health Med. 2000 Mar;22(1):90-8. (PMID: 10774910)
PLoS One. 2021 Apr 16;16(4):e0248236. (PMID: 33861742)
PLoS One. 2015 Oct 29;10(10):e0141455. (PMID: 26513240)
BMC Health Serv Res. 2008 Jun 21;8:134. (PMID: 18570677)
Trop Med Int Health. 2011 Mar;16(3):334-42. (PMID: 21159080)
Indian J Pediatr. 1996 Mar-Apr;63(2):133-7. (PMID: 10829979)
N Z Med J. 2019 Aug 30;132(1501):79-88. (PMID: 31465331)
Vaccine. 2012 Jan 5;30(2):168-79. (PMID: 22108489)
Lancet. 2010 Jul 17;376(9736):160. (PMID: 20638558)
PLoS One. 2021 Sep 16;16(9):e0257277. (PMID: 34529714)
Vaccine. 2011 Dec 30;29 Suppl 4:D74-9. (PMID: 22486980)
Health Policy Plan. 2010 Jan;25(1):50-60. (PMID: 19749011)
Vaccine. 2015 Jun 9;33(25):2862-80. (PMID: 25944299)
Rural Remote Health. 2013;13(3):2380. (PMID: 24016257)
Vaccine. 2011 Mar 21;29(14):2555-60. (PMID: 21300101)
Pan Afr Med J. 2019 Jan 16;32:28. (PMID: 31143333)
Soc Sci Med. 1991;33(2):185-92. (PMID: 1909462)
J Trop Med Hyg. 1993 Jun;96(3):139-45. (PMID: 8505766)
Indian Pediatr. 1990 Nov;27(11):1165-9. (PMID: 2081638)
BMC Public Health. 2015 Feb 12;15:137. (PMID: 25885862)
Indian J Pediatr. 1996 Jan-Feb;63(1):99-103. (PMID: 10829972)
Cochrane Database Syst Rev. 2011 Jul 06;(7):CD008145. (PMID: 21735423)
Vaccine. 2010 Apr 26;28(19):3473-8. (PMID: 20199756)
Int J Health Serv. 1990;20(4):717-25. (PMID: 2125030)
PLoS One. 2021 Jan 22;16(1):e0245893. (PMID: 33481942)
BMC Public Health. 2018 Jan 16;18(1):144. (PMID: 29338782)
Trop Doct. 1993 Apr;23(2):79-81. (PMID: 8488582)
Hum Vaccin Immunother. 2013 Aug;9(8):1752-4. (PMID: 23974831)
J Health Econ. 2009 May;28(3):611-21. (PMID: 19233495)
Lancet. 2011 Apr 23;377(9775):1421-8. (PMID: 21515164)
J Pak Med Assoc. 2003 Mar;53(3):98-101. (PMID: 12779022)
Lancet Glob Health. 2017 Apr;5(4):e428-e438. (PMID: 28288747)
Vaccine. 2014 Apr 25;32(20):2294-9. (PMID: 24631083)
Vaccine. 2013 Jan 30;31(6):987-93. (PMID: 23246258)
Int J Public Health. 2020 Dec;65(9):1785-1795. (PMID: 33140237)
Am J Prev Med. 2000 May;18(4):343-50. (PMID: 10788739)
Bull World Health Organ. 1986;64(6):861-5. (PMID: 3493855)
JMIR Mhealth Uhealth. 2019 Apr 15;7(4):e11245. (PMID: 30985281)
Afr Health Sci. 2021 Jun;21(2):951-959. (PMID: 34795755)
J Health Econ. 2015 Dec;44:226-37. (PMID: 26519909)
Zhonghua Liu Xing Bing Xue Za Zhi. 1999 Apr;20(2):78-80. (PMID: 10682537)
Health Econ. 2018 Dec;27(12):2087-2106. (PMID: 30159944)
Vaccine. 2000 Feb 18;18 Suppl 1:S46-8. (PMID: 10683546)
BMJ Open. 2014 Jan 14;4(1):e004302. (PMID: 24430882)
Biometrics. 1992 Jun;48(2):577-85. (PMID: 1637980)
Hum Vaccin Immunother. 2015;11(1):72-82. (PMID: 25483518)
MMWR Recomm Rep. 1999 Jun 18;48(RR-8):1-15. (PMID: 10428099)
Cochrane Database Syst Rev. 2013 May 31;(5):CD010038. (PMID: 23728698)
J Infect Dis. 2012 Mar;205 Suppl 1:S56-64. (PMID: 22315387)
J Multidiscip Healthc. 2021 Jan 06;14:9-19. (PMID: 33442259)
J Pak Med Assoc. 2004 Dec;54(12):610-3. (PMID: 16104487)
J Pak Med Assoc. 2017 Nov;67(11):1719-1722. (PMID: 29171567)
J Ayub Med Coll Abbottabad. 2021 Jan-Mar;33(1):139-144. (PMID: 33774971)
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-8. (PMID: 28319453)
Indian J Public Health. 2019 Oct-Dec;63(4):334-340. (PMID: 32189654)
Int J Epidemiol. 2016 Apr;45(2):451-9. (PMID: 26874927)
Bull World Health Organ. 2008 Feb;86(2):140-6. (PMID: 18297169)
Mhealth. 2017 Jul 19;3:26. (PMID: 28828373)
Lancet Glob Health. 2017 Jun;5(6):e593-e603. (PMID: 28495264)
BMC Public Health. 2012 Jul 31;12:578. (PMID: 22849711)
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S2. (PMID: 19828060)
Health Policy Plan. 2002 Dec;17(4):412-9. (PMID: 12424213)
Bull World Health Organ. 2001;79(2):150-8. (PMID: 11242822)
East Mediterr Health J. 2005 Jul;11(4):745-52. (PMID: 16700391)
Bull World Health Organ. 1994;72(3):409-22. (PMID: 8062399)
J Public Health Afr. 2019 Jun 19;10(1):1032. (PMID: 31285815)
Bull World Health Organ. 2010 Feb;88(2):97-103. (PMID: 20428366)
Adv Exp Med Biol. 2011;697:1-8. (PMID: 21120715)
BMC Public Health. 2016 Feb 16;16:152. (PMID: 26880141)
JMIR Mhealth Uhealth. 2020 Sep 21;8(9):e20356. (PMID: 32955455)
JMIR Mhealth Uhealth. 2015 Jan 14;3(1):e4. (PMID: 25589367)
Lancet. 2008 Sep 13;372(9642):928-39. (PMID: 18790316)
Vaccine. 2020 Jan 16;38(3):433-443. (PMID: 31806532)
Implement Sci. 2011 Dec 02;6:125. (PMID: 22132930)
BMJ Open. 2015 Sep 18;5(9):e007972. (PMID: 26384721)
Lancet. 2005 Oct 1;366(9492):1163-4. (PMID: 16198762)
Br Med J (Clin Res Ed). 1988 Jun 11;296(6637):1654-6. (PMID: 3135060)
Implement Sci. 2015 Mar 08;10:30. (PMID: 25889485)
Public Health. 2008 Sep;122(9):949-58. (PMID: 18313703)
BMJ. 2010 May 17;340:c2220. (PMID: 20478960)
Bull World Health Organ. 2007 Sep;85(9):688-94. (PMID: 18026625)
J Clin Epidemiol. 2005 Nov;58(11):1081-8. (PMID: 16223649)
Vaccine. 2019 May 21;37(23):3050-3060. (PMID: 31036457)
PLoS Med. 2018 Mar 6;15(3):e1002519. (PMID: 29509769)
J Ayub Med Coll Abbottabad. 2015 Oct-Dec;27(4):853-7. (PMID: 27004338)
Vaccine. 2016 May 5;34(21):2437-2443. (PMID: 27026145)
JAMA. 2007 Oct 24;298(16):1867-75. (PMID: 17954538)
BMC Health Serv Res. 2020 Feb 26;20(1):144. (PMID: 32102649)
Vaccine. 2009 Jan 14;27(3):467-72. (PMID: 18996423)
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S11. (PMID: 19828055)
BMC Public Health. 2020 Jul 11;20(1):1086. (PMID: 32652969)
Lancet. 2008 Nov 1;372(9649):1579-89. (PMID: 18984192)
EClinicalMedicine. 2022 Jun 25;50:101500. (PMID: 35784436)
Digit Health. 2020 Feb 20;6:2055207620905411. (PMID: 32128233)
Vaccine. 2014 Apr 17;32(19):2150-9. (PMID: 24598724)
Vaccine. 2019 Oct 23;37(45):6814-6823. (PMID: 31564451)
BMC Int Health Hum Rights. 2013 May 11;13:23. (PMID: 23663327)
BMC Public Health. 2016 Aug 31;16:909. (PMID: 27581655)
JMIR Mhealth Uhealth. 2021 Jun 15;9(6):e27603. (PMID: 34128813)
Bull Pan Am Health Organ. 1988;22(3):250-68. (PMID: 3147117)
BMC Public Health. 2011 Jul 18;11:573. (PMID: 21767403)
Lancet. 2006 Feb 4;367(9508):394-5. (PMID: 16458759)
BMC Med. 2013 Mar 14;11:66. (PMID: 23497441)
Annu Rev Public Health. 2015 Mar 18;36:393-415. (PMID: 25785892)
Infect Dis Poverty. 2018 Nov 30;7(1):119. (PMID: 30497515)
Med J Malaysia. 1976 Sep;31(1):17-9. (PMID: 1023007)
Bull World Health Organ. 2015 May 1;93(5):339-346C. (PMID: 26229205)
East Mediterr Health J. 2013 Feb;19(2):125-9. (PMID: 23516821)
Syst Rev. 2019 Jun 28;8(1):154. (PMID: 31253186)
Bull Soc Pathol Exot. 2016 Aug;109(3):185-91. (PMID: 27160219)
Trop Med Int Health. 2001 Jul;6(7):526-8. (PMID: 11469945)
Pediatr Infect Dis J. 2007 Jun;26(6):496-500. (PMID: 17529866)
Cochrane Database Syst Rev. 2014 Nov 19;(11):CD010232. (PMID: 25408540)
Vaccine. 2008 Apr 7;26(16):1926-33. (PMID: 18343540)
Bull World Health Organ. 1995;73(5):589-95. (PMID: 8846484)
Lancet Glob Health. 2017 Apr;5(4):e377-e378. (PMID: 28288737)
PLoS Med. 2013;10(3):e1001405. (PMID: 23526886)
BMJ Glob Health. 2020 Dec;5(12):. (PMID: 33293295)
BMC Public Health. 2011 Apr 17;11:239. (PMID: 21496343)
PLoS Med. 2021 Feb 18;18(2):e1003523. (PMID: 33600451)
Przegl Epidemiol. ;71(3):439-455. (PMID: 29186941)
Health Policy Plan. 2018 Apr 1;33(3):392-400. (PMID: 29351604)
Lancet. 2013 Apr 13;381(9874):1283-92. (PMID: 23453283)
PLoS One. 2012;7(5):e37905. (PMID: 22662247)
J Egypt Public Health Assoc. 1992;67(1-2):75-86. (PMID: 1295951)
Am J Prev Med. 2004 Nov;27(4):327-52. (PMID: 15488364)
PLoS One. 2014 Mar 11;9(3):e90347. (PMID: 24618584)
Health Policy. 2015 Jun;119(6):770-7. (PMID: 25686796)
J Community Health. 2016 Apr;41(2):265-73. (PMID: 26395786)
P N G Med J. 1989 Jun;32(2):97-100. (PMID: 2816078)
BMC Public Health. 2011 Oct 14;11:806. (PMID: 21999521)
BMJ Glob Health. 2019 Apr 03;4(2):e001232. (PMID: 31139442)
Cochrane Database Syst Rev. 2009 Oct 07;(4):CD008137. (PMID: 19821444)
BMJ. 1998 Mar 14;316(7134):805-11. (PMID: 9549449)
S Afr Med J. 1991 Apr 20;79(8):433-6. (PMID: 2020881)
Vaccine. 2020 Aug 27;38(38):5966-5978. (PMID: 32620374)
Arch Pediatr Adolesc Med. 1995 Aug;149(8):902-5. (PMID: 7633545)
Am J Med. 2015 Oct;128(10):1139.e1-5. (PMID: 26087045)
Vaccine. 2020 Sep 29;38(42):6600-6608. (PMID: 32788139)
BMC Public Health. 2021 Feb 2;21(1):266. (PMID: 33530963)
P N G Med J. 1993 Sep;36(3):228-33. (PMID: 8059549)
JMIR Public Health Surveill. 2018 Mar 07;4(1):e20. (PMID: 29514773)
Int J Epidemiol. 1990 Sep;19(3):685-92. (PMID: 2262265)
BMC Health Serv Res. 2017 Dec 4;17(Suppl 2):703. (PMID: 29219093)
BMC Public Health. 2018 Apr 23;18(1):534. (PMID: 29688845)
Cochrane Database Syst Rev. 2016 Jul 10;7:CD008145. (PMID: 27394698)
Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004015. (PMID: 20238326)
Vaccine. 2011 Oct 26;29(46):8215-21. (PMID: 21893149)
BMC Health Serv Res. 2014 Feb 04;14:52. (PMID: 24495533)
J Trop Med Hyg. 1989 Dec;92(6):386-90. (PMID: 2607571)
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941. (PMID: 29342498)
Int J Epidemiol. 1994 Jun;23(3):624-31. (PMID: 7960392)
Lancet. 2004 Dec 4-10;364(9450):2030-7. (PMID: 15582060)
Trop Med Int Health. 2011 Sep;16(9):1044-53. (PMID: 21707877)
Bull World Health Organ. 1996;74(5):517-24. (PMID: 9002332)
Vaccine. 2018 Oct 22;36(44):6567-6577. (PMID: 29162321)
HSMHA Health Rep. 1971 Dec;86(12):1112-21. (PMID: 5157797)
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73. (PMID: 23584253)
Vaccine. 2016 Jan 4;34(2):276-283. (PMID: 26647290)
Trans R Soc Trop Med Hyg. 2010 Sep;104(9):577-82. (PMID: 20609454)
Bull World Health Organ. 1999;77(2):119-26. (PMID: 10083709)
Hum Vaccin. 2010 Jun;6(6):455-61. (PMID: 20543585)
Syst Rev. 2013 Nov 21;2:106. (PMID: 24262139)
Arch Pediatr Adolesc Med. 1994 Sep;148(9):908-14. (PMID: 8075732)
BMJ. 1997 Sep 20;315(7110):703-7. (PMID: 9314754)
JAMA. 1996 Aug 28;276(8):626-30. (PMID: 8773635)
Arch Dis Child. 2020 Jan;105(1):18-25. (PMID: 31270097)
Lancet. 2013 Apr 27;381(9876):1499-506. (PMID: 23582721)
BMJ. 2008 May 3;336(7651):995-8. (PMID: 18456631)
J Public Health (Oxf). 2017 Dec 1;39(4):805-812. (PMID: 27915261)
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S5. (PMID: 19828063)
Cad Saude Publica. 2019 Nov 28;35(12):e00214518. (PMID: 31800789)
BMC Int Health Hum Rights. 2009 Oct 14;9 Suppl 1:S8. (PMID: 19828066)
معلومات مُعتمدة: 001 International WHO_ World Health Organization
المشرفين على المادة: 0 (Vaccines)
تواريخ الأحداث: Date Created: 20231206 Date Completed: 20231207 Latest Revision: 20240716
رمز التحديث: 20240716
مُعرف محوري في PubMed: PMC10698843
DOI: 10.1002/14651858.CD008145.pub4
PMID: 38054505
قاعدة البيانات: MEDLINE
الوصف
تدمد:1469-493X
DOI:10.1002/14651858.CD008145.pub4